Literature DB >> 10401564

Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

S Latini1, F Bordoni, F Pedata, R Corradetti.   

Abstract

1. The application of an ischaemic insult in hippocampal slices results in the depression of synaptic transmission, mainly attributed to the activation of A1 adenosine receptors by adenosine released in the extracellular space. 2. To estimate the concentration of endogenous adenosine acting at the receptor level during an ischaemic episode, we recorded field e.p.s.ps (fe.p.s.ps) from hippocampal slices, and evaluated the ability of the selective A1 receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), to reverse the fe.p.s.p. depression induced by in vitro ischaemia. A relationship between the IC50 of an antagonist and the endogenous concentration of a neurotransmitter has been used for pharmacological analysis. 3. The complete and reversible depression of fe.p.s.p. in the CA1 region induced by 5 min ischaemia was decreased in the presence of DPCPX (50-500 nM). 8-Phenyltheophylline (10 microM) abolished the depression of fe.p.s.ps during the ischaemic period, while a small (peak effect 12 +/- 4%) decrease in fe.p.s.ps was observed during the initial phase of reperfusion. 4. In the time-interval of maximal depression of fe.p.s.ps., IC50 and adenosine concentration changed as function of time with a good degree of correlation. The maximal value of adenosine concentration was 30 microM. 5. Our data provide an estimation of the adenosine concentration reached at the receptor level during an ischaemic episode, with a higher time discrimination (15 s) than that achieved with any biochemical approach. This estimation may be useful in order to establish appropriate concentrations of purinergic compounds to be tested for their pharmacological effects during an ischaemic episode.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401564      PMCID: PMC1566061          DOI: 10.1038/sj.bjp.0702591

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  48 in total

1.  The selective A2 adenosine receptor agonist CGS 21680 enhances excitatory transmitter amino acid release from the ischemic rat cerebral cortex.

Authors:  M H O'Regan; R E Simpson; L M Perkins; J W Phillis
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

Review 2.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

3.  Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses.

Authors:  T V Dunwiddie; L Diao
Journal:  J Pharmacol Exp Ther       Date:  1994-02       Impact factor: 4.030

4.  Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia.

Authors:  A Héron; D Lekieffre; E Le Peillet; F Lasbennes; J Seylaz; M Plotkine; R G Boulu
Journal:  Brain Res       Date:  1994-04-04       Impact factor: 3.252

5.  Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus.

Authors:  L G Wu; P Saggau
Journal:  Neuron       Date:  1994-05       Impact factor: 17.173

6.  Evidence for the presence of excitatory A2 adenosine receptors in the rat hippocampus.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Neurosci Lett       Date:  1992-04-13       Impact factor: 3.046

7.  Effect of K+ depolarization, tetrodotoxin, and NMDA receptor inhibition on extracellular adenosine levels in rat striatum.

Authors:  M Pazzagli; F Pedata; G Pepeu
Journal:  Eur J Pharmacol       Date:  1993-03-30       Impact factor: 4.432

8.  In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors.

Authors:  M Pazzagli; C Corsi; S Latini; F Pedata; G Pepeu
Journal:  Eur J Pharmacol       Date:  1994-03-21       Impact factor: 4.432

Review 9.  Neuroprotective role of adenosine in cerebral ischaemia.

Authors:  K A Rudolphi; P Schubert; F E Parkinson; B B Fredholm
Journal:  Trends Pharmacol Sci       Date:  1992-12       Impact factor: 14.819

10.  Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions.

Authors:  F Pedata; S Latini; A M Pugliese; G Pepeu
Journal:  J Neurochem       Date:  1993-07       Impact factor: 5.372

View more
  40 in total

1.  Changes in hippocampal adenosine efflux, ATP levels, and synaptic transmission induced by increased temperature.

Authors:  S A Masino; S Latini; F Bordoni; F Pedata; T V Dunwiddie
Journal:  Synapse       Date:  2001-07       Impact factor: 2.562

2.  Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices.

Authors:  Elisabetta Coppi; Anna Maria Pugliese; Holger Stephan; Christa E Müller; Felicita Pedata
Journal:  Purinergic Signal       Date:  2007-01-03       Impact factor: 3.765

3.  A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro.

Authors:  Anna Maria Pugliese; Elisabetta Coppi; Giampiero Spalluto; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  Adenosine modulates excitatory synaptic transmission and suppresses neuronal death induced by ischaemia in rat spinal motoneurones.

Authors:  Nobuyuki Miyazaki; Terumasa Nakatsuka; Daisuke Takeda; Kazuhiro Nohda; Kazuhide Inoue; Munehito Yoshida
Journal:  Pflugers Arch       Date:  2008-06-27       Impact factor: 3.657

5.  Syzygium cumini is more effective in preventing the increase of erythrocytic ADA activity than phenolic compounds under hyperglycemic conditions in vitro.

Authors:  Karine S De Bona; Gabriela Bonfanti; Paula E R Bitencourt; Lariane O Cargnelutti; Priscila S da Silva; Thainan P da Silva; Régis A Zanette; Aline S Pigatto; Maria B Moretto
Journal:  J Physiol Biochem       Date:  2014-01-10       Impact factor: 4.158

Review 6.  Neuroadaptations in adenosine receptor signaling following long-term ethanol exposure and withdrawal.

Authors:  Tracy R Butler; Mark A Prendergast
Journal:  Alcohol Clin Exp Res       Date:  2011-07-18       Impact factor: 3.455

Review 7.  Tryptophan, adenosine, neurodegeneration and neuroprotection.

Authors:  T W Stone; C M Forrest; G M Mackay; N Stoy; L G Darlington
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

8.  Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors.

Authors:  Anna Maria Pugliese; Serena Latini; Renato Corradetti; Felicita Pedata
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

9.  A1 adenosine receptors mediate hypoxia-induced ventriculomegaly.

Authors:  Christopher P Turner; Meltem Seli; Laura Ment; William Stewart; Henglin Yan; Bjorn Johansson; Bertil B Fredholm; Michael Blackburn; Scott A Rivkees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

10.  Neurological basis of AMP-dependent thermoregulation and its relevance to central and peripheral hyperthermia.

Authors:  Mirko Muzzi; Francesco Blasi; Alessio Masi; Elisabetta Coppi; Chiara Traini; Roberta Felici; Maria Pittelli; Leonardo Cavone; Anna Maria Pugliese; Flavio Moroni; Alberto Chiarugi
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-24       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.